PIPELINE
RevolKa is developing therapeutic drug candidates for various diseases and new industrial proteins, taking advantage of the wide range of indications by aiProtein®.
| Project | Modality | Area | Development Stage | Partner |
| RKD001 | Protein | Therapeutics (Rare Disease) |
Lead Discovery |  |
| RKD002 | Protein | Therapeutics (Rare Disease) |
Lead Discovery | |
| RK001 | Antibody | Therapeutics (Immunooncotherapy) |
Technology development | |
| RK002 | Antibody | Therapeutics (Oncology) |
Technology development | |
| RK003 | Protein | Therapeutics (Rare Disease) |
Undisclosed |  |
| RK004 | Protein | Undisclosed | Undisclosed |  |
| RK006 | Coming soon | |||
| RK007 | Coming soon | |||
| RK008 | Coming soon | |||
| RK009 | Protein | Vaccines (Infectious diseases) |
Research collaboration |  |